GlassScriptPhysician profile
Angela Bowman
NPI 1629329032
$2,295.91
in general payments reported to CMS, 2019-2025
18 companies · $702 in 2025
The $702 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $317 · 2023: $45.63 · 2024: $1,023 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $362.48 | 2024-2025 | Ajovy, Austedo Xr, Uzedy |
| Novo Nordisk INC | $249.27 | 2021-2025 | Wegovy |
| Neurocrine Biosciences, INC. | $177.56 | 2022-2025 | |
| Boston Scientific Corporation | $149.63 | 2022 | |
| Abiomed | $139.14 | 2024 | Impella |
| Alexion Pharmaceuticals, INC. | $133.92 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $123.08 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $121.35 | 2024 | Uptravi, Opsumit |
| Phathom Pharmaceuticals, INC. | $116.10 | 2025 | Voquezna |
| Pfizer INC. | $112.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $99.08 | 2025 | Invega Sustenna |
| Eisai INC. | $93.70 | 2025 | |
| Janssen Scientific Affairs, LLC | $91.48 | 2024 | Xarelto |
| Amarin Pharma, INC. | $90.92 | 2024 | |
| Acadia Pharmaceuticals INC | $84.74 | 2024 | Nuplazid |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $70.76 | 2025 | |
| Molnlycke Health Care US, LLC | $45.63 | 2023 | Mepilex Border Sacrum, Mepilex Border Flex, Mepilex Border Em |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.